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Background The risk of malignant melanoma associated with histologically dysplas-
tic naevi (HDN) has not been defined. While clinically atypical naevi appear to
confer an independent risk of melanoma, no study has evaluated the extent to
which HDN are predictive of melanoma.
Objectives To estimate the risk of melanoma associated with HDN. Secondarily, the
risk associated with number of naevi and large naevi is estimated.
Methods We enrolled 80 patients with newly diagnosed melanoma along with 80
spousal controls. After obtaining information on melanoma risk factors and per-
forming a complete cutaneous examination, the most clinically atypical naevus was
biopsied in both cases and controls. Histological dysplasia was then assessed inde-
pendently by 13 dermatopathologists (0, no dysplasia; 1, mild dysplasia; 2, moder-
ate dysplasia; 3, severe dysplasia). The dermatopathologists were blinded as to
whether the naevi were from melanoma subjects or controls. Multivariate analyses
were performed to determine if there was an independent association between the
degree of histological dysplasia in naevi and a personal history of melanoma.
Results In persons with naevi receiving an average score of > 1 (i.e. naevi consid-
ered to have greater than mild histological dysplasia), there was an increased risk
of melanoma [odds ratio (OR) 2Æ60, 95% confidence interval (CI) 0Æ99–6Æ86]
which persisted after adjustment for confounders (OR 3Æ99, 95% CI 1Æ02–
15Æ71). Very few dermatopathologists reliably graded naevi of subjects with mel-
anoma as being more dysplastic than naevi of control subjects. Among the entire
group, the interobserver reliability associated with grading histological dysplasia
in naevi was poor (weighted kappa 0Æ28).
Conclusions HDN do appear to confer an independent risk of melanoma. However,
this result may add more to our biological understanding of melanoma risk than
to clinical assessment of risk, because HDN assessed by a single pathologist gen-
erally cannot be used to assess risk of melanoma. Future studies should be direc-
ted at establishing reproducible, predictive criteria for grading naevi.
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The atypical or dysplastic melanocytic naevus accounts for
650 000 new patient visits annually to U.S. dermatologists.1 It
is a defining feature of melanoma high-risk groups such as the
atypical mole syndrome, although it occurs much more com-
monly as a sporadic finding in otherwise healthy individuals.
Despite their prevalence, sporadic dysplastic naevi remain a
poorly defined entity. A recent survey of dermatologists sug-
gests that there exists a substantial degree of variation in how
the dysplastic naevus is defined and treated.1 Others remain
sceptical of its existence.2 When defined clinically (pigmented
lesions > 5 mm with any number of features including colour
variegation, border irregularity and asymmetry) atypical naevi
appear to confer an independent risk for malignant melan-
oma.3–8 However, the histopathological correlates of clinical
atypia are inconsistent,9 and while some advocate defining the
dysplastic naevus histologically,10,11 no study has determined
melanoma risk associated with histological dysplasia. Previous
studies have found melanocytic dysplasia to be a common his-
tological finding in the general white-skinned population, sug-
gesting that it is not a strong predictor of melanoma.12
Given this controversy, we utilized a case–control design to
evaluate the risk of invasive malignant melanoma associated
with histologically dysplastic naevi (HDN). We further exam-
ined whether this relationship was independent of the effects
of naevus count or the presence of large naevi, which are risk




Eighty cases of invasive malignant melanoma were enrolled
between 1998 and 2001. Cases were patients with incident
melanoma under evaluation in outpatient dermatology and
oncology clinics at the University of Washington Medical Cen-
ter. In addition, 80 unaffected spousal controls were accrued.
In two cases, same-sex domestic partners were enrolled as
controls. A matched design was chosen to minimize variation
in other risk factors (thus increasing precision of the model),
as spouses tend to be matched on a number of important mel-
anoma risk factors such as race, residence and socioeconomic
status. Spouses were also selected as the control group because
they are typically motivated to participate in medical studies,
and we asked controls to undergo a cutaneous examination
and biopsy. The study was approved by the Institutional
Review Board of the Human Subjects Division, University of
Washington Medical Center.
Data collection
Full cutaneous examinations were performed by a dermatol-
ogy fellow (S.K.). The most clinically atypical macular naevus
was biopsied in both cases and controls. Clinical atypia was
subjectively assessed by a combination of size, macularity, col-
our variegation, asymmetry and border irregularity. Thirteen
dermatopathologists separately reviewed all histological sec-
tions blinded to the status of the subject, and each assigned a
dysplasia score of: 0, no dysplasia; 1, mild dysplasia; 2, mod-
erate dysplasia; or 3, severe dysplasia. All dermatopathologists
have a special interest in melanocytic lesions and interpret
atypical (dysplastic) naevi on a daily basis. In order to re-cre-
ate the current standard of practice, there was no discussion
or consensus about criteria in grading histological dysplasia
prior to the review of the study set. All the dermatopatholo-
gists graded dysplasia by the criteria they use in their daily
practice, based on their understanding of the medical litera-
ture. The basic features of naevomelanocytic dysplasia have
been published elsewhere.10,15,16
Naevus counts were performed on the back. An individual
was considered to have large naevi if a single naevus on the
back measured > 5 mm. Freckles on the shoulders (0–10,
11–50, > 50) were likewise tabulated, in addition to eye col-
our and Fitzpatrick skin type (I–VI). Hair colour was obtained
by asking the participant their natural hair colour at 15 years.
Enrolled subjects completed a questionnaire concerning demo-
graphic characteristics including age, education, income, cur-
rent residence, birth residence and occupation. In addition,
information on personal cancer history (all-site cancer history
and specifically nonmelanoma and melanoma skin cancers)
and family history of melanoma in first-degree relatives was
obtained. Sunburn history was defined as the lifetime number
of blistering sunburns. Sensitivity to intermittent and chronic
sun exposure was estimated by asking participants their ten-
dency to burn (‘If your skin is exposed to strong sunlight for
the first time in summer for 1 h, would you: get a severe sun-
burn with blistering; have a painful sunburn for a few days
followed by peeling; get mildly burnt followed by some
degree of tanning; tan without any sunburn?’) and ability to
tan (‘After repeated and prolonged exposure to sunlight your
skin becomes: deeply tanned; moderately tanned; only mildly
tanned; only freckled or no suntan at all?’). Other estimates of
ultraviolet (UV) exposure were obtained, including the num-
ber of weeks spent in sunny resorts, use of tanning beds or
use of UV radiation for medical conditions.
Data analysis
The three main risk factors of interest were the dysplasia score
of the most clinically atypical naevus (obtained as a group
average of each dermatopathologist’s score), number of naevi
on the back and presence or absence of a large naevus. Risk of
melanoma associated with dysplasia was calculated for individ-
ual pathologists as well as for the overall group-averaged dys-
plasia score. The average score is reported as a dichotomous
variable (£ 1 and > 1). Several cutoffs were considered. The
strongest risk of melanoma was seen for naevi with an average
dysplasia score of > 1. Because this group can also be inter-
preted as naevi with greater than mild dysplasia, it was chosen
as the cutoff. A weighted kappa statistic was calculated to esti-
mate the interobserver reliability between pathologists in gra-
ding mild, moderate, severe and no dysplasia. A weighted
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kappa statistic accounts for the magnitude of disagreement
when using ordinal data.17
Given the inherent matching with a spousal referent group,
conditional logistic regression was performed in all analyses.
Odds ratios (ORs) and 95% confidence intervals (CIs) for the
relation between the risk factors and melanoma risk were
computed as age- and sex-adjusted ORs, as well as a fully
adjusted OR, which included adjustment of all confounders.
Inclusion of potential confounders in the fully adjusted model
was determined by addition of the strongest predictors in a
stepwise fashion into the logistic regression model. To estab-
lish the relative contribution of large naevi, naevus counts and
histological dysplasia to melanoma risk, each of these variables
was also reported with mutual adjustment of the other predic-
tors. Data analysis was performed using Intercooled STATA 8.0
software (College Station, TX, U.S.A.).
Results
Table 1 presents the distribution of demographic and melan-
oma risk factors in the study and gives the estimated risk of
melanoma associated with these factors in this population.
Cases were 56% male, with a mean age of 47 years (range
25–75), and controls were 41% male with a mean age of
48 years (range 23–77). Given that spouses are to some extent
matched on age, CIs for the risk of melanoma with age were
wide and nonsignificant, although cases tended to be older
than controls. Both groups were generally college educated.
More cases than controls attended college or obtained a gradu-
ate degree, and while this was not statistically significant, vari-
ance estimates were wide, consistent with some degree of
matching. History of nonmelanoma skin cancer was strongly
associated with melanoma risk, as to a lesser extent was family
history of melanoma. Personal characteristics such as red or
blond hair, blue or green eyes, and Fitzpatrick skin type I and
II were all associated with melanoma risk. More than 50
freckles on the shoulder was a significant risk factor for mel-
anoma (OR 3Æ72, 95% CI 1Æ23–11Æ24). A lifetime history of
more than six blistering sunburns was also statistically signifi-
cant (OR 4Æ58, 95% CI 1Æ23–17Æ00). More cases than controls
had a strong tendency to burn and no or mild ability to tan.
Table 2 presents the estimated risk of melanoma associated
with histological dysplasia in naevi, presence of a large naevus
(> 5 mm) on the back, and naevus counts on the back. ORs
and 95% CIs were calculated after adjustment for age and sex,
as well as in a full model that included the dysplasia score,
naevus counts on the back and large naevi, as well as eye col-
our, Fitzpatrick skin type, history of severe sunburns and fam-
ily history of melanoma. The presence of at least one large
naevus on clinical examination was not significantly associated
with melanoma risk (age- and sex-adjusted OR 1Æ81, 95% CI
0Æ75–4Æ37, fully adjusted model OR 2Æ52, 95% CI 0Æ67–9Æ42).
Naevus counts were associated with melanoma risk (for ‡ 10
naevi on back: age- and sex-adjusted OR 3Æ68, 95% CI 1Æ38–
9Æ80, P for trend 0Æ01, fully adjusted model OR 4Æ25, 95% CI
0Æ99–18Æ3, P for trend 0Æ04). Average dysplasia scores were
low, with only 17Æ5% of specimens receiving an average score
> 1, and only one biopsy receiving an average score > 2. An
average dysplasia score of > 1 was associated with a statisti-
cally significantly increased risk of melanoma in the age- and
sex-adjusted model (OR 2Æ60, 95% CI 0Æ99–6Æ86), and
remained an independent risk factor after adjustment for num-
ber of naevi and other risk factors (OR 3Æ99, 95% CI 1Æ02–
15Æ71).
Table 3 presents each individual pathologist’s dysplasia
score. This reflects to what degree melanoma subjects’ naevi
Table 1 Age- and sex-adjusted odds ratios (ORs) and 95% confidence
intervals (CIs) for risk of melanoma
Risk factor Cases Controls OR (95% CI)
Sex
Female 35 47 1
Male 45 33 1Æ25 (0Æ78–2Æ02)
Age (years)
< 41 27 28 1
41–51 26 29 1Æ47 (0Æ12–18Æ03)
> 51 27 23 3Æ37 (0Æ21–55Æ12)
Education
High school 13 17 1
College 51 49 2Æ23 (0Æ75–6Æ64)
Graduate degree 15 14 2Æ56 (0Æ61–10Æ83)
History of NMSC
No 65 77 1
Yes 14 3 11Æ89 (1Æ52–92Æ53)
Family history of melanoma
No 61 73 1
Yes 17 7 2Æ91 (1Æ05–8Æ10)
Hair colour
Brown/black 49 63 1
Red/blond 31 17 2Æ72 (1Æ23–6Æ03)
Eye colour
Brown 8 24 1
Blue 42 37 5Æ4 (1Æ55–18Æ83)
Green 30 19 9Æ08 (2Æ27–36Æ29)
Fitzpatrick skin type
III/IV 48 60 1
I/II 32 20 2Æ25 (1Æ10–4Æ60)
Freckles, shoulders
0–10 17 31 1
11–50 22 18 2Æ62 (0Æ94–7Æ31)
> 50 41 31 3Æ72 (1Æ23–11Æ24)
Blistering burns (lifetime)
None 10 18 1
1–3 37 39 2Æ12 (0Æ67–6Æ63)
4–6 12 12 2Æ54 (0Æ61–10Æ54)
> 6 20 11 4Æ58 (1Æ23–17Æ00)
Tendency to burn
Mild or no burn 43 49 1
Severe or painful
burn
36 31 1Æ37 (0Æ70–2Æ68)
Ability to tan
Moderate to deep 50 56 1
None or mild 29 20 2Æ16 (0Æ99–4Æ72)
NMSC, nonmelanoma skin cancer.
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demonstrated more histological dysplasia than naevi from con-
trol subjects, as graded by individual pathologists blinded to
the status of cases and controls. Of the 13 pathologists, only
one had scores which significantly correlated with melanoma
risk. This individual graded naevi more often as moderate or
severe in melanoma subjects (OR 5Æ52, 95% CI 1Æ13–26Æ97),
although the scores of several others had high but not statisti-
cally significant ORs. Interobserver reliability was poor, with a
weighted kappa statistic of 0Æ28. However, when a group
average was used, the histological grading was predictive of
melanoma.
Discussion
We found HDN to be more common in patients with melan-
oma than in controls. This association was independent of
naevus counts, as well as other well-known risk factors for
melanoma. Our utilization of 13 pathologists provides stability
to an entity which is variably defined and recognized. While
there are numerous case–control studies examining the
importance of clinically atypical naevi, this is the first study
designed to evaluate an independent melanoma risk associated
with HDN.
Several previous studies have suggested an association
between HDN and melanoma. In a retrospective review of
HDN, persons with a history of melanoma were more likely
to have a severely (OR 4Æ08, 95% CI 2Æ91–5Æ7) or moderately
(OR 1Æ45, 95% CI 1Æ13–1Æ87) dysplastic naevus vs. a mildly
dysplastic naevus. This study depended on providers reporting
a melanoma history in the pathology accession, and adjust-
ment for other confounders such as naevus counts could not
be performed.18 A similar study of archived pathology data
found that 57% of persons with HDN had a history of melan-
oma, while if the naevus was considered ‘questionably dys-
plastic’ or nondysplastic, only 25% and 18% had a history of
melanoma, respectively.19 Bergman et al.20 similarly reported
that markedly atypical naevi were more likely to arise in per-
sons with a history of melanoma. Half of their cohort
belonged to melanoma kindreds, a small subpopulation clearly
at increased risk of melanoma, making the results difficult to
interpret.
Other studies have not demonstrated a relationship between
melanoma risk and histological dysplasia. Piepkorn et al.12
found mild dysplasia in the naevi of 7–32% of a healthy pop-
ulation, suggesting that dysplasia is common and not a strong
predictor of melanoma. Another study compared naevi from
persons with dysplastic naevi with a control population, find-
ing a nonsignificant trend towards more dysplasia among the
group with dysplastic naevi. No adjustments for confounders
could be performed.15 Klein and Barr21 examined clinically
benign naevi in healthy individuals, and found that 88% had
at least one feature of dysplasia, and 29% had three features.
Our study does demonstrate an independent risk associated
with HDN, although the interpretation of our cutoff is
important. All naevi in the study (both cases and controls)
were graded as at least mildly dysplastic by at least one
pathologist. The excess risk was seen only in naevi in which
the group average was > 1, or naevi in which the average
group score was greater than mild. Most naevi graded as mild
by an individual pathologist are not associated with an
increased risk of melanoma. These results are also corrobor-
ated by a previous study showing that one begins to observe
DNA aneuploidy in dysplastic naevi that are graded as moder-
ately atypical.22
HDN appear to be an independent risk factor for melan-
oma, perhaps reflecting the pleiotropic effects of genetic and
environmental aetiological factors that are common between
the two entities. A population-based study evaluated biopsies
of the two most clinically atypical naevi from a single individ-
ual, and demonstrated a significant correlation, suggesting that
some persons have a predisposition to melanocytic dysplasia.23
Some argue that a substantial proportion of melanomas arises
from dysplastic naevi. Our study was not designed to examine
any potential precursor role of the HDN. To date, no study
has evaluated the prophylactic excision of dysplastic naevi as a
modality of melanoma prevention.
Table 2 Odds ratios (ORs) and 95%
confidence intervals (CIs) reporting the
relative contribution of histological dysplasia
in naevi,a naevus counts and presence of at
least one large naevus (> 5 mm) towards
melanoma risk
Risk factor Cases Controls OR (95% CI)b OR (95% CI)c
Average dysplasia score
£ 1 61 71 1 1
> 1 19 9 2Æ60 (0Æ99–6Æ86) 3Æ99 (1Æ02–15Æ71)
Naevi on back
0–4 12 23 1 1
5–9 17 28 1Æ27 (0Æ48–3Æ34) 0Æ71 (0Æ19–2Æ69)
‡ 10 51 29 3Æ68 (1Æ38–9Æ80) 4Æ25 (0Æ99–18Æ3)
P for trend 0Æ01 0Æ04
Naevi > 5 mm
None on back 57 65 1 1
At least 1 on back 23 15 1Æ81 (0Æ75–4Æ37) 2Æ52 (0Æ67–9Æ42)
aMost clinically atypical naevus biopsied, and average histological dysplasia scores deter-
mined by North American Dysplastic Nevus Panel. bAge- and sex-adjusted. cMutual adjust-
ment of other risk factors, in addition to adjustment for age, sex, eye colour, Fitzpatrick
skin type, history of severe sunburns and family history of melanoma.
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Several limitations should be mentioned. The potential for
recall bias exists for many of our covariates such as personal
or family history of cancer, number of sunburns and sun sen-
sitivity. Assessment of pigmentary characteristics by a single
clinical dermatologist unblinded to the status of subjects is
a possible source of bias. In addition, having a single
Table 3 Risk of melanoma for individual
pathologists’ interpretation of dysplasiaPathologist Cases Controls OR (95% CI)a
1
No dysplasia 34 37 1
Mild dysplasia 34 27 1Æ35 (0Æ64–2Æ82)
Moderate or severe dysplasia 12 16 0Æ64 (0Æ24–1Æ65)
2
No dysplasia 29 29 1
Mild dysplasia 40 44 0Æ75 (0Æ35–1Æ59)
Moderate or severe dysplasia 11 7 1Æ32 (0Æ41–4Æ18)
3
No dysplasia 37 36 1
Mild dysplasia 20 26 0Æ67 (0Æ29–1Æ59)
Moderate or severe dysplasia 23 18 1Æ07 (0Æ47–2Æ47)
4
No dysplasia 48 51 1
Mild dysplasia 26 26 1Æ00 (0Æ49–1Æ99)
Moderate or severe dysplasia 6 3 2Æ01 (0Æ44–9Æ29)
5
No dysplasia 58 66 1
Mild dysplasia 19 12 1Æ61 (0Æ72–3Æ61)
Moderate or severe dysplasia 3 2 1Æ50 (0Æ24–9Æ51)
6
No dysplasia 49 53 1
Mild dysplasia 22 25 0Æ86 (0Æ41–1Æ81)
Moderate or severe dysplasia 9 2 7Æ05 (0Æ85–58Æ33)
7
No dysplasia 44 44 1
Mild dysplasia 29 35 0Æ84 (0Æ44–1Æ61)
Moderate or severe dysplasia 7 1 6Æ20 (0Æ72–52Æ63)
8
No dysplasia 37 46 1
Mild dysplasia 25 19 1Æ52 (0Æ72–3Æ22)
Moderate or severe dysplasia 18 15 1Æ30 (0Æ54–3Æ12)
9
No dysplasia 40 52 1
Mild dysplasia 30 24 1Æ65 (0Æ80–3Æ44)
Moderate or severe dysplasia 10 4 5Æ02 (0Æ96–26Æ39)
10
No dysplasia 27 32 1
Mild dysplasia 32 35 0Æ98 (0Æ49–1Æ98)
Moderate or severe dysplasia 21 13 2Æ00 (0Æ76–5Æ23)
11
No dysplasia 37 37 1
Mild dysplasia 24 31 0Æ65 (0Æ30–1Æ39)
Moderate or severe dysplasia 19 12 1Æ50 (0Æ53–4Æ25)
12
No dysplasia 44 49 1
Mild dysplasia 23 26 0Æ85 (0Æ43–1Æ70)
Moderate or severe dysplasia 13 5 5Æ52 (1Æ13–26Æ97)
13
No dysplasia 67 72 1
Mild dysplasia 12 8 2Æ13 (0Æ75–6Æ01)
Moderate or severe dysplasia 1 0 2Æ3E+14 (0–¥)
OR, odds ratio; CI, confidence interval. aAge- and sex-adjusted odds ratios. Interobserver
reliability for no, mild, moderate or severe dysplasia was estimated as poor (weighted
kappa statistic 0Æ28).
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dermatologist choose the most clinically atypical naevi may
not be generalizable. However, it is difficult to imagine how
this might have systematically contributed to a bias. Import-
antly, no biopsied specimen was considered to be an entity
other than a melanocytic naevus by the majority of patholo-
gists. If melanomas removed in the cases arose from HDN,
our estimates of risk associated with HDN may be conserva-
tive. Lastly, the cumulative dysplasia scores were low, which
accounts for the variance in our estimates of the risk associ-
ated with moderate to severe dysplasia.
The variability in grading of dysplasia is troubling. Our
kappa statistic of 0Æ28 reflects agreement on a group of naevi
which were on average mildly dysplastic and cannot be com-
pared directly with previous studies that have examined sam-
ples more representative of the spectrum of atypia. None the
less, most other studies demonstrate similar poor to fair inter-
observer reliability.12,24 When predefined criteria are used,
interobserver agreement generally improves somewhat.25–27
Future studies should determine which histological features
are most useful in predicting melanoma risk so that universal
criteria can be developed.
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